We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

191 hedge funds and large institutions have $3.81B invested in NEVRO CORP. in 2019 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 23

90% more call options, than puts

Call options by funds: $41.5M | Put options by funds: $21.9M

36% more capital invested

Capital invested by funds: $2.79B → $3.81B (+$1.02B)

22% more funds holding

Funds holding: 156191 (+35)

2% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 56

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
191
Holders Change
+35
Holders Change %
+22.44%
% of All Funds
3.76%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
60
Increased
57
Reduced
56
Closed
23
Calls
$41.5M
Puts
$21.9M
Net Calls
+$19.6M
Net Calls Change
+$49.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
126
Bank of Montreal
Ontario, Canada
$568K +$148K +1,490 +45%
WAM
127
Wolverine Asset Management
Illinois
$561K +$473K +4,781 New
XK
128
Xact Kapitalforvaltning
Sweden
$559K
UBS Group
129
UBS Group
Switzerland
$551K -$178K -1,801 -28%
OAM
130
Oxford Asset Management
United Kingdom
$532K +$448K +4,525 New
PIM
131
Partner Investment Management
California
$531K -$124K -1,252 -22%
ProShare Advisors
132
ProShare Advisors
Maryland
$477K +$64.3K +649 +19%
AI
133
Atria Investments
North Carolina
$471K +$7.82K +79 +2%
Qube Research & Technologies (QRT)
134
Qube Research & Technologies (QRT)
United Kingdom
$459K +$386K +3,902 New
QSS
135
Quantitative Systematic Strategies
Florida
$451K +$382K +3,854 New
FCI
136
Financial Counselors Inc
Kansas
$447K
AG
137
Aperio Group
California
$441K -$33.1K -334 -8%
Capital Fund Management (CFM)
138
Capital Fund Management (CFM)
France
$423K +$357K +3,600 New
HMS
139
Hanseatic Management Services
New Mexico
$400K +$337K +3,407 New
AC
140
Athanor Capital
New York
$364K +$307K +3,100 New
HSBC Holdings
141
HSBC Holdings
United Kingdom
$361K -$7.72K -78 -2%
AG
142
Advisor Group
Arizona
$354K -$8.91K -90 -3%
Sumitomo Mitsui Trust Group
143
Sumitomo Mitsui Trust Group
Japan
$347K +$292K +2,949 New
CCIA
144
Campbell & Co Investment Adviser
Maryland
$325K +$274K +2,767 New
Robeco Institutional Asset Management
145
Robeco Institutional Asset Management
Netherlands
$315K +$265K +2,677 New
GCP
146
GSA Capital Partners
United Kingdom
$315K +$266K +2,684 New
Public Employees Retirement Association of Colorado
147
Public Employees Retirement Association of Colorado
Colorado
$314K
AIP
148
Ameritas Investment Partners
Nebraska
$307K +$17.8K +180 +7%
Prudential Financial
149
Prudential Financial
New Jersey
$300K -$23K -232 -8%
CANY
150
Caxton Associates (New York)
New York
$297K +$250K +2,524 New

NVRO Hedge Fund Activity: Q4 2019 in Review

191 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2019, worth a combined $3.81B — up 36% from $2.79B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new NVRO positions and 23 closed out — a net gain of 37 holders — while 57 added to existing stakes and 56 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $38.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $71.7M.

  • 191 institutional investors held NEVRO CORP. (NVRO) as of Q4 2019, up from 156 in Q3 2019.
  • Funds reported $3.81B of NEVRO CORP. stock for Q4 2019, up 36% quarter-over-quarter.
  • 60 funds opened new NEVRO CORP. positions in Q4 2019 and 23 closed out, a net change of +37 holders.
  • The largest NEVRO CORP. buyer in Q4 2019 was Victory Capital Management, an estimated $38.7M added.
  • The largest NEVRO CORP. seller in Q4 2019 was T. Rowe Price Associates, an estimated $71.7M sold.

Based on aggregated 13F filings for Q4 2019.